Home Featured Page 14

Featured

Latest

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride

High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

Oakland Psychedelic Conference

The Science Behind How Psychedelics Inspire Creative Breakthroughs

Psychedelic Funding Update: Q3 2024

The Hero’s Journey: Finding Your Story in Psychedelic Healing

Illuminating the Hidden Self: Navigating the Jungian Shadow with Psychedelics

Healing Psychedelics: Where Science Meets Spirit

Pα+ Psychedelic Bulletin #175: atai Sells a Third of Compass Stake;...

The Hidden Roots of Australia’s Psychedelic Underground

The Globalization of Ayahuasca, Psychedelic Parenting, and the Power of Ceremony

The Psychedelics Lobby: Tracking Federal Lobbying by Psychedelics Companies and Nonprofits

Tripped: The Connection Between LSD, Nazi Germany, and MKUltra

1...131415...285 Page 14 of 285

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and...

High Hopes in the Mile High City: Inside Colorado’s First Licensed...

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride

High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

Psychedelic Science 2025

Oakland Psychedelic Conference

The Science Behind How Psychedelics Inspire Creative Breakthroughs

Psychedelic Funding Update: Q3 2024

The Hero’s Journey: Finding Your Story in Psychedelic Healing

Illuminating the Hidden Self: Navigating the Jungian Shadow with Psychedelics

Healing Psychedelics: Where Science Meets Spirit

Pα+ Psychedelic Bulletin #175: atai Sells a Third of Compass Stake;...

The Hidden Roots of Australia’s Psychedelic Underground

The Globalization of Ayahuasca, Psychedelic Parenting, and the Power of Ceremony

The Psychedelics Lobby: Tracking Federal Lobbying by Psychedelics Companies and Nonprofits

Tripped: The Connection Between LSD, Nazi Germany, and MKUltra

EDITOR PICKS

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and...

High Hopes in the Mile High City: Inside Colorado’s First Licensed...

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY